Newsroom

Elektronenmikroskopische Aufnahme von Staphylokokken auf HeLa-Zellen.
News
Funding for the development of an inhibitor against hospital germs
Hospital-acquired bacterial pneumonia is the most frequent nosocomial infection. It is mostly caused by the bacterium Staphylococcus aureus, which in many cases is already resistant to commonly used antibiotics and is therefore difficult to treat. A team from the Helmholtz Centre for Infection Research (HZI) in cooperation with the Lead Discovery Center GmbH (LDC), a spin-off of Max Planck Innovation and the Max Planck Society e.V., aims to further develop a drug that prevents staphylococci from colonizing the lungs. The research team will now receive milestone-dependent funding of initially 1.33 million US dollars from the non-profit organization CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), with CARB-X anticipating a further 7.44 million US dollars depending on the progress of the project.
01.12.2020
HZI Campus
Die entwickelten Pathoblocker inaktivieren das Enzym LasB und entwaffnen somit den Krankheitserreger Pseudomonas aeruginosa.
News
Important step in fighting resistant bacteria
01.12.2020
HZI Campus
HIPS
Prof. Alice McHardy und Prof. Jörg Vogel
News
Two HZI scientists honoured as “Highly-cited researchers”
The annual list of “Highly-cited researchers” identifies scientists who have demonstrated a significant impact in their chosen field over the last ten years through the publication of several highly-cited papers. This year, the Braunschweig Helmholtz Centre for Infection Research (HZI) has two researchers on the list: bioinformatician Prof Alice McHardy and biochemist Prof Jörg Vogel. The ranking by Clarivate Analytics, a company specialising in bibliometric data, includes more than 6,100 researchers.
30.11.2020
HZI Campus
HIRI
Von Monozyten abgeleitete dendritische Zellen nach einer Infektion mit dem Zytomegalievirus (grün) und dem Schimmelpilz Aspergillus fumigatus (rot).
News
Coinfection: More than the sum of its parts
Infections with two pathogens pose a serious threat in the clinics. Researchers from Würzburg and Jena have developed a technique that provides new insights into this process and can be used as an early warning system. The research results have now been published in the journal Cell Reports.
18.11.2020
HIRI
Portrait Jörg Vogel
News
Jörg Vogel announced as new president of the Academy of Microbiology
Professor Jörg Vogel (Würzburg, Germany) has been announced as the President of the European Academy of Microbiology (EAM) from 1 January 2021. Prof Vogel will take over from Prof Philippe Sansonetti, the former President of the Academy since 2012. He thanked and acknowledged his predecessor and stated his intent to “continue to promote microbiology as a field of study and recognize excellence within its practice”. Vogel also outlined his vision to “work to grow the size and reputation of the Academy” and emphasized the importance of international scientific cooperation. Vogel is a German microbiologist in the field of RNA biology, and is the Founding Director of the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI). He also directs the Institute of Molecular Infection Biology (IMIB) of the Medical Faculty at the University of Würzburg in Bavaria, Germany, and has been a member of the EAM since 2015.
17.11.2020
HIRI
Arme und Hände die auf einer Tastatur liegen
News
PhD-Programm BIOMEDAS gestartet
Mit der Auftaktveranstaltung am 12. November 2020 ist BIOMEDAS offiziell gestartet. Das neue Doktorandenprogramm wurde von der Translationsallianz in Niedersachsen (TRAIN) initialisiert und ist an die Hannover Biomedical Research School (HBRS) der Medizinischen Hochschule Hannover (MHH) angegliedert. Für fünfzehn Datenwissenschaftler beginnt damit ihre strukturierte Doktorandenausbildung.
12.11.2020
TWINCORE
CiiM

HZI in the media

Seuchen aus dem KI-Labor: Kann Künstliche Intelligenz bereits Biowaffen bauen?

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel
Impfung sinnvoll? Erst Erkältungen, dann Corona und Grippe – So schützen Sie sich

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

14.10.2026
|
DIE WELT
HMN 2026: How crawling motility may be far older than previously thought

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network
Neue Empfehlungen der WHO zur COVID-19-Impfung

... in der Abteilung „Virale Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI), hat die WHO als externer ...

13.10.2026
|
DeutschesGesundheitsPortal
Metax brings genome-wide coverage into focus for sharper microbial profiling

tool called Metax, developed by researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and described in the

12.10.2026
|
Bioengineer.org
New Hope for Fighting C. difficile Infections

parts of the microbiome. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. “We

12.10.2026
|
Technology Networks
HZI erhält 724.000 Euro: Makrophagen sollen Lungenfibrose bekämpfen

... auch gezielte Forschungsmittel an das Helmholtz-Zentrum für Infektionsforschung (HZI): Die Forschungsgruppe von Prof ...

12.10.2026
|
Ad Hoc News
Fieser Magen-Darm-Erreger breitet sich immer stärker aus: Infektionen in England steigen drastisch

... nur in England vor. Laut Angaben des Helmholtz Zentrum für Infektionsforschung ist es dem Erreger ...

12.10.2026
|
Frankfurter Rundschau online
EU fördert Entwicklung von Immunzelltherapie bei Lungenfibrose

... und Belgien. Aus Deutschland sind das Helmholtz-Zentrum für Infektionsforschung (HZI), das Fraunhofer-Institut für Toxikologie und ...

12.10.2026
|
MTA Dialog
Forscher entwickeln Wirkstoff gegen Pockenviren

... weitere Versuche herstellen.

 

Auch das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ist beteiligt. Die ...

11.10.2026
|
t-online.de
Warum Ballaststoffe nicht bei jedem gleich wirken

... unterschiedlichen Regionen unterscheidet. Der Forscher vom Helmholtz-Zentrum für Infektionsforschung konnte in seiner Studie zeigen, ...

10.10.2026
|
rbb radioeins
Gut bacteria team up with diet to decide who rules the microbiome

Tawk, Youssef El Mouali and colleagues at the Helmholtz Centre for Infection Research, together with collaborators at the University of

09.10.2026
|
Bioengineer.org

Register now for the HZI newsletter